BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
10 juil. 2024 07h15 HE
|
Biostem Technologies
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
27 juin 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of...
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
26 juin 2024 08h30 HE
|
Biostem Technologies
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
25 juin 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
17 juin 2024 14h07 HE
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
17 juin 2024 10h17 HE
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
ViaDerma Provides Highlights of Quarterly Financial Report
06 juin 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
AVITA Medical Achieves Milestone with First Case Using RECELL GO
05 juin 2024 16h25 HE
|
AVITA Medical
Joseph M. Still Burn Center at Doctors Hospital of Augusta treats first patient using AVITA Medical’s FDA-Approved RECELL GO System.
AVITA Medical Announces FDA Approval of RECELL GO
30 mai 2024 09h15 HE
|
AVITA Medical
AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.
BioStem Technologies to Sponsor MRO Better Half Dash
29 mai 2024 11h00 HE
|
Biostem Technologies
BioStem Technologies to Sponsor MRO Better Half Dash